Another systematic review and meta-analysis revealed that genetic variants within the angiotensin-converting enzyme 1 and 2 genes (ACE and ACE2, respectively) and the transmembrane serine protease 2 (TMPRSS2) gene were associated with COVID-19 severity [28]. The gene discussed is ACE2; the disease is COVID-19.